Cancer May Lower HDL Cholesterol, Study Finds
Cancer may lower good, HDL cholesterol and low total cholesterol may be a sign of undiagnosed cancer, a long-running study following nearly thirty thousand men for almost 20 years has discovered. A related study suggests that lowering total cholesterol may help men reduce risk of high-grade prostate cancer.
Scientists have discovered that combining interleukin-7 (IL-7) – a key component of the immune system – with a viral vaccine improves the ability of the immune system to attack tumors. A Canadian team at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital, Toronto say their discovery could be included in new clinical trials that use a patient’s own cells to destroy tumors.
In patients with prostate cancer undergoing prostatectomy, Magnetic Resonance Imaging (MRI) can play an important role in determining if the cancer is restricted to the prostate gland or if it has spread beyond the capsule.
This is the finding of a study performed at the University of California, Los Angeles, CA. The study included a review of 119 patients who were referred for prostate MRI prior to prostatectomy.
“Results showed that MRI correctly identified 87 out of 92 (95%) of patients with T2 and 6 out of 8 (75%) of patients with T3 disease (T2 means the disease is organ confined and T3 means the disease has locally spread beyond the prostate),” said Timothy McClure, MD, lead author of the study. Steven Raman, MD, worked with Dr. McClure on this study.
People with diabetes at the time of a cancer diagnosis have an increased risk of death compared to patients without diabetes, according to a study led by Frederick Brancati, M.D., Johns Hopkins University and published in the December 17 issue of The Journal of the American Medical Association today.
Harping on negative consequences of a lack of cancer screening among minorities can actually make African-Americans less likely to go for screening, according to behavioral science research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.